AGP Executive Report
Last update: 10 hours agoBiopharma Manufacturing & Compliance: EVERSANA’s Vikram Anand says FDA transparency shows many drug applications stall at pharmacovigilance and safety-readiness gaps, with 37% of submissions receiving CRLs and an average ~2.5 years from CRL to approval. GMP Expansion: WuXi XDC secured GMP release for its Singapore BCM3 “dual-function” line for antibody intermediates and conjugated drug substances, boosting overseas capacity. Regulation & Consumer Impact: California became the first state to restrict sales of less-efficient replacement tires starting 2029, aiming to cut fuel use and emissions while raising industry cost concerns. Industrial Security: UN experts warn that used pharmaceutical and lab equipment can be diverted via secondary markets into illicit drug production, urging tighter controls. Workforce & Food Manufacturing: Bridgetown Natural Foods is expanding its Wilson County granola-bar operation, adding more local jobs with 100 openings still available. Mobility Product Launch: BraunAbility introduced LiftSentinel, a retrofit lift barrier for commercial wheelchair lifts. AI Hardware IPO Watch: China’s Unitree Robotics begins trading after an IPO oversubscribed thousands of times, spotlighting humanoid-robot manufacturing momentum. Energy & Data Centers: AEP Ohio and major data-center firms pledge $18M to help residents pay rising electricity bills tied to grid strain.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
